课题基金 / 基金详情

A NONHUMAN PRIMATE MODEL OF TICK IMMUNITY

A NONHUMAN PRIMATE MODEL OF TICK IMMUNITY
蜱免疫的非人类灵长类动物模型
批准号:
7562397
负责人:
SUKANYA NARASIMHAN
金额:
$1.4万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-05-01 至 2008-04-30

项目摘要

项目成果

SUKANYA NARASIMHAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The tick Ixodes scapularis is an important vector for pathogens responsible for Lyme disease, rickettsial disease, anaplasmosis, babesiosis, and tick-borne encephalitis. There is an unmet need for safe and effective vaccines against these pathogens. Vaccines directed against the tick vector would potentially target multiple pathogens transmitted by the tick. During the process of obtaining a blood meal, ticks transmit the pathogens they harbor. Tick salivary gland components are involved in the establishment and regulation of tick feeding as well as pathogen transmission. Immunity directed against these salivary components may block tick feeding and pathogen transmission. However defining these crucial salivary components remains a daunting task and a tick vaccine, elusive. Acquired tick immunity is a phenomenon whereby the vertebrate host, upon repeated tick infestation, effectively rejects ticks within 12-24 hours after tick attachment and also blocks pathogen transmission. Host immunity directed against crucial tick salivary antigens presumably plays a pivotal role in tick rejection and in the consequent impairment of pathogen transmission. Defining tick salivary antigens that elicit tick immunity provides an approach to identify 'the' crucial tick salivary antigens that can serve as vaccine targets to thwart tick feeding and to block pathogen transmission. The focus of this pilot proposal is to assess acquired tick-immunity in non-human primate (NHP) in the context of transmission of Borrelia burgdorferi, the causative agent of Lyme disease. An animal model that demonstrates both tick immunity and Lyme disease does not currently exist. We hypothesize that the NHP may serve as such an animal model. Proving this hypothesis would clearly enhance studies aimed at defining tick salivary antigens that are crucial for eliciting tick-immunity and for pathogen transmission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1
  • 批准号:
    10461961
  • 项目类别:
  • 资助金额:
    $29.95万
  • 财政年份:
    2021
  • 负责人:
    SUKANYA NARASIMHAN
  • 依托单位:
A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1
  • 批准号:
    10256453
  • 项目类别:
  • 资助金额:
    $29.95万
  • 财政年份:
    2021
  • 负责人:
    SUKANYA NARASIMHAN
  • 依托单位:
Importance of Immunogenic salivary glycans in eliciting resistance to ticks
  • 批准号:
    9386568
  • 项目类别:
  • 资助金额:
    $22.19万
  • 财政年份:
    2017
  • 负责人:
    SUKANYA NARASIMHAN
  • 依托单位:
A Multivalent Lyme Disease Vaccine Targeting Tick-Host-Pathogen Interactions
  • 批准号:
    8876575
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2014
  • 负责人:
    SUKANYA NARASIMHAN
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究